Dehydroepiandrosterone sulfate levels and risk of atrial fibrillation: The Rotterdam Study

Addressing the growing burden of atrial fibrillation: evidence, sustainability and accessibility more important than territory

(2012) Alexander M Clark et al.   European Journal of Preventive Cardiology

The Rotterdam Study: 2012 objectives and design update

(2011) Albert Hofman et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Nicotine, cigarette smoking and cardiac arrhythmia: an overview

(2011) Alessandra D'Alessandro et al.   European Journal of Preventive Cardiology

Dehydroepiandrosterone sulfate is inversely associated with sex-dependent diverse carotid atherosclerosis regardless of endothelial function

(2010) Sumiko Yoshida et al.   ATHEROSCLEROSIS

Low Serum Levels of Dehydroepiandrosterone Sulfate Predict All-Cause and Cardiovascular Mortality in Elderly Swedish Men

(2010) Claes Ohlsson et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

DHEA-S Levels and Cardiovascular Disease Mortality in Postmenopausal Women: Results from the National Institutes of Health—National Heart, Lung, and Blood Institute (NHLBI)-Sponsored Women’s Ischemia Syndrome Evaluation (WISE)

(2010) Chrisandra Shufelt et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Cardiovascular Disease Is Associated with Greater Incident Dehydroepiandrosterone Sulfate Decline in the Oldest Old: The Cardiovascular Health Study All Stars Study

(2010) Jason L. Sanders et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Adrenal androgen dehydroepiandrosterone sulfate inhibits vascular remodeling following arterial injury

(2009) Masaaki Ii et al.   ATHEROSCLEROSIS

Serum DHEA-S Level Is Associated with the Presence of Atherosclerosis in Postmenopausal Women with Type 2 Diabetes Mellitus

(2008) Ippei KANAZAWA et al.   ENDOCRINE JOURNAL

New risk factors for atrial fibrillation: causes of 'not-so-lone atrial fibrillation'

(2008) B. A. Schoonderwoerd et al.   EUROPACE